Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer

NCT03238495 is registered in ClinicalTrials.gov with Qamar Khan as lead sponsor.

NCT NCT03238495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Lead sponsor
Qamar Khan
Phase
Phase 2
Overall status
Unknown status
Start date
August 15, 2017
Completion date
June 1, 2023
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer